A network for sharing data and resources to improve cancer treatment
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
This study is all about helping cancer treatments work better by bringing researchers together to share information and find out how tumors resist therapies, so that patients can eventually receive more personalized and effective treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-10175624 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness of cancer therapies by creating a collaborative network that shares data and resources among researchers. It aims to identify how tumors resist treatments and how they can be made more sensitive to therapies. By utilizing advanced analytical methods and fostering teamwork among experts, the project seeks to streamline the development of new cancer treatments and improve existing ones. Patients may benefit from the insights gained through this collaborative effort, which could lead to more personalized and effective treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with various types of cancers who may benefit from innovative treatment approaches.
Not a fit: Patients with non-malignant conditions or those not diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment strategies that are more effective and tailored to individual patient needs.
How similar studies have performed: Previous research has shown success in collaborative approaches to cancer treatment, indicating that this methodology is promising and has the potential for significant advancements.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.